نتائج البحث - "Indirect treatment comparison"

المساهمون: Casadei-Gardini, A., Rimassa, L., Rimini, M., Yoo, C., Ryoo, B. -Y., Lonardi, S., Masi, G., Kim, H. -D., Vivaldi, C., Ryu, M. -H., Rizzato, M. D., Salani, F., Bang, Y., Pellino, A., Catanese, S., Burgio, V., Cascinu, S., Cucchetti, A.

العلاقة: info:eu-repo/semantics/altIdentifier/wos/WOS:000630834000003; volume:147; issue:12; firstpage:3665; lastpage:3671; numberofpages:7; journal:JOURNAL OF CANCER RESEARCH AND CLINICAL ONCOLOGY; http://hdl.handle.net/20.500.11768/125267Test; info:eu-repo/semantics/altIdentifier/scopus/2-s2.0-85103171083

الإتاحة: https://doi.org/20.500.11768/125267Test
https://doi.org/10.1007/s00432-021-03602-wTest
https://hdl.handle.net/20.500.11768/125267Test

View record in BASE

85

Survival, Motor Function, and Motor Milestones: Comparison of AVXS-101 Relative to Nusinersen for the Treatment of Infants with Spinal Muscular Atrophy Type 1

المؤلفون: Douglas E. Feltner, Irina Pivneva, Martin Cloutier, Eric Q. Wu, Ramesh Arjunji, O. Dabbous, Annie Guerin, Douglas M. Sproule, Benit Maru, Jeroen P. Jansen, Maria Lorenzi

المصدر: Advances in Therapy

الوصول الحر: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::e36535eccac12d04ad591848174ebad0Test
https://doi.org/10.1007/s12325-019-00923-8Test

86

Comparative efficacy of inhaled medications (ICS/LABA, LAMA, LAMA/LABA and SAMA) for COPD: a systematic review and network meta-analysis

المؤلفون: Ling Eng Tan, Gerald Seng Wee Chua, Mohamed Ismail Abdul Aziz, Ping-Tee Tan, Fiona Pearce, David Bin-Chia Wu, Liang Lin, Kwong Ng

المصدر: International Journal of Chronic Obstructive Pulmonary Disease

مصطلحات موضوعية: medicine.medical_specialty, Network Meta-Analysis, Respiratory System Agents, Review, mixed treatment comparison, Muscarinic Antagonists, chronic obstructive pulmonary disease, 03 medical and health sciences, chemistry.chemical_compound, Pulmonary Disease, Chronic Obstructive, 0302 clinical medicine, Internal medicine, frequentist meta-analysis, Forced Expiratory Volume, Administration, Inhalation, medicine, Humans, 030212 general & internal medicine, anticholinergics, Adrenergic beta-2 Receptor Agonists, Fluticasone, Randomized Controlled Trials as Topic, COPD, biology, business.industry, indirect treatment comparison, Olodaterol, General Medicine, Lama, biology.organism_classification, medicine.disease, respiratory tract diseases, Treatment Outcome, 030228 respiratory system, chemistry, Indacaterol, Vilanterol, Formoterol, Salmeterol, business, hormones, hormone substitutes, and hormone antagonists, medicine.drug

الوصول الحر: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::78b00364d6d97de017cce2a5e2fc600fTest
http://europepmc.org/articles/PMC6186767Test

87

Regorafenib versus cabozantinb as second-line treatment after sorafenib for unresectable hepatocellular carcinoma: matching-adjusted indirect comparison analysis

المؤلفون: Hyung-Don Kim, Margherita Rimini, Andrea Casadei-Gardini, Alessandro Cucchetti, Francesca Salani, Gianluca Masi, Yeonghak Bang, Changhoon Yoo, Sara Lonardi, Lorenza Rimassa, Silvia Catanese, Valentina Burgio, Stefano Cascinu, Caterina Vivaldi, Baek-Yeol Ryoo, Mario Domenico Rizzato, Min-Hee Ryu, Antonio Pellino

المساهمون: Casadei-Gardini, A., Rimassa, L., Rimini, M., Yoo, C., Ryoo, B. -Y., Lonardi, S., Masi, G., Kim, H. -D., Vivaldi, C., Ryu, M. -H., Rizzato, M. D., Salani, F., Bang, Y., Pellino, A., Catanese, S., Burgio, V., Cascinu, S., Cucchetti, A.

مصطلحات موضوعية: 0301 basic medicine, Oncology, Male, Cancer Research, Pyridines, Targeted therapy, chemistry.chemical_compound, 0302 clinical medicine, Anilides, Cabozantinib, CELESTIAL, Hepatocellular carcinoma (HCC), Indirect treatment comparison, Matching-adjusted indirect comparison (MAIC), Regorafenib, RESORCE, Second-line, Systemic therapy, Adult, Aged, Carcinoma, Hepatocellular, Clinical Trials, Phase III as Topic, Female, Humans, Liver Neoplasms, Middle Aged, Phenylurea Compounds, Progression-Free Survival, Salvage Therapy, Sorafenib, General Medicine, Phase III as Topic, 030220 oncology & carcinogenesis, Hepatocellular carcinoma, medicine.drug, medicine.medical_specialty, Placebo, 03 medical and health sciences, Internal medicine, medicine, Clinical Trials, Second line treatment, business.industry, Proportional hazards model, Carcinoma, Hepatocellular, medicine.disease, Indirect comparison, 030104 developmental biology, chemistry, business

الوصول الحر: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::6f8ee6780c4621c91020e3b72a30aa15Test
http://hdl.handle.net/11568/1111031Test

88

Indirect treatment comparison of biologics in chronic rhinosinusitis with nasal polyps

المؤلفون: Yingxin Xu, Claus Bachert, Anju T. Peters, Leda Mannent, Siddhesh Kamat, Joseph K. Han, Chien-Chia Chuang, Philippe Gevaert, Enrico Heffler, Binod Neupane, Jerome Msihid, Patricia Guyot, Peter Hellings

المساهمون: Ear, Nose and Throat

المصدر: JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY-IN PRACTICE
Journal of Allergy and Clinical Immunology: In Practice, 9(6), 2461-2471.e5

مصطلحات موضوعية: medicine.medical_specialty, Immunology, Population, Omalizumab, Nasal congestion, Dupilumab, Placebo, law.invention, 03 medical and health sciences, Nasal Polyps, 0302 clinical medicine, Randomized controlled trial, INFLAMMATION, law, Internal medicine, medicine, Medicine and Health Sciences, Humans, Immunology and Allergy, Nasal polyps, 030212 general & internal medicine, education, Rhinitis, Biological Products, education.field_of_study, Science & Technology, Intention-to-treat analysis, EOSINOPHILIA, business.industry, MEPOLIZUMAB, CRSwNP, medicine.disease, SLEEP, ALLERGY, Treatment Outcome, 030228 respiratory system, Chronic Disease, Quality of Life, Indirect treatment comparison, ASTHMA, medicine.symptom, business, SINUS SURGERY, Life Sciences & Biomedicine, ENDOTYPES, medicine.drug

وصف الملف: application/pdf; Print-Electronic

الوصول الحر: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::15f51cf6936349cf02272af3129cd056Test
https://hdl.handle.net/1854/LU-8743241Test

89

Comparative Efficacy of Cabozantinib and Ramucirumab After Sorafenib for Patients with Hepatocellular Carcinoma and Alpha-fetoprotein ≥ 400 ng/mL: A Matching-Adjusted Indirect Comparison

المؤلفون: Lidia Martin, Jörg Trojan, Yuxin Li, Fabio Piscaglia, Marino Venerito, Renata Zaucha, Florence Marteau, P Mollon, Debashis Sarker, Ho Yeong Lim, Qing Xu, Bruno Daniele

المساهمون: Trojan J., Mollon P., Daniele B., Marteau F., Martin L., Li Y., Xu Q., Piscaglia F., Zaucha R., Sarker D., Lim H.Y., Venerito M.

المصدر: Advances in Therapy

مصطلحات موضوعية: Oncology, Sorafenib, Adult, 030213 general clinical medicine, medicine.medical_specialty, Carcinoma, Hepatocellular, Cabozantinib, Pyridines, Population, Antibodies, Monoclonal, Humanized, Tyrosine kinase inhibitor (TKI), Ramucirumab, Monoclonal antibody (mAb), 03 medical and health sciences, chemistry.chemical_compound, 0302 clinical medicine, Internal medicine, medicine, Clinical endpoint, Humans, Pharmacology (medical), Anilides, Hepatocellular carcinoma (HCC), Adverse effect, education, Original Research, Matching-adjusted indirect comparison (MAIC), education.field_of_study, second-line treatment / 2L treatment, business.industry, Liver Neoplasms, Vascular endothelial growth factor (VEGF), Indirect treatment comparison (ITC), General Medicine, medicine.disease, Discontinuation, chemistry, 030220 oncology & carcinogenesis, Hepatocellular carcinoma, alpha-Fetoproteins, Alpha-fetoprotein (AFP), business, medicine.drug

وصف الملف: ELETTRONICO

الوصول الحر: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::89c3aa9afe58ea47cabce4fe25c8f123Test
https://hdl.handle.net/11585/858948Test

90

Non-optimal methodology questions indirect treatment comparison of dupilumab vs. other biologics in severe asthma

المؤلفون: Nicolas Molinari, Arnaud Bourdin

المساهمون: MORNET, Dominique, Physiologie & médecine expérimentale du Cœur et des Muscles [U 1046] (PhyMedExp), Institut National de la Santé et de la Recherche Médicale (INSERM)-Centre National de la Recherche Scientifique (CNRS)-Université de Montpellier (UM), Centre Hospitalier Régional Universitaire [Montpellier] (CHRU Montpellier), Institut Montpelliérain Alexander Grothendieck (IMAG), Centre National de la Recherche Scientifique (CNRS)-Université de Montpellier (UM)

المصدر: Respiratory Medicine
Respiratory Medicine, 2022, 191, pp.105999. ⟨10.1016/j.rmed.2020.105999⟩

مصطلحات موضوعية: Pulmonary and Respiratory Medicine, medicine.medical_specialty, Severe asthma, Dupilumab, Antibodies, Monoclonal, Humanized, [SDV.MHEP.PSR]Life Sciences [q-bio]/Human health and pathology/Pulmonology and respiratory tract, Indirect Treatment, Humans, Medicine, [SDV.IMM.ALL]Life Sciences [q-bio]/Immunology/Allergology, Intensive care medicine, ComputingMilieux_MISCELLANEOUS, Mepolizumab, Biological Products, [STAT.ME] Statistics [stat]/Methodology [stat.ME], Severe eosinophilic asthma, business.industry, Benralizumab, Matching-adjusted indirect comparison, [SDV.IMM.IMM]Life Sciences [q-bio]/Immunology/Immunotherapy, Asthma, Indirect treatment comparison, [SDV.MHEP.PSR] Life Sciences [q-bio]/Human health and pathology/Pulmonology and respiratory tract, [SDV.IMM.IMM] Life Sciences [q-bio]/Immunology/Immunotherapy, business, [STAT.ME]Statistics [stat]/Methodology [stat.ME], [SDV.IMM.ALL] Life Sciences [q-bio]/Immunology/Allergology

وصف الملف: application/pdf

الوصول الحر: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::34ee373dc7046b83972de5b518e380deTest
https://doi.org/10.1016/j.rmed.2020.105999Test

تنقيح النتائج